logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2010 or most recent year available

Part (iv) All hallucinogen inpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium100000000000
Bulgaria00010000101
Czech Republic00100000101
Denmark00000000000
Germany00231110808
Estonia:::::::::::
Ireland00001100202
Greece00012000303
Spain:::::::::::
France00001000101
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg00010000101
Hungary00100000101
Malta:::::::::::
Netherlands0642282510341180118
Austria00001000101
Poland201010000202
Portugal:::::::::::
Romania0241220011011
Slovenia:::::::::::
Slovakia00000010101
Finland00000100101
Sweden00200000202
Uk30035402014014
Croatia00101000202
Turkey:::::::::::
Norway0223200110010
Total01158444015751800180
 

Notes:

: Indicates no data are available.

(1) In Belgium if the exact primary drug is not known, the generic category is recorded. In 2010 there were 96 Opiates, 1 Cocaine and 1 Hypnotics and Sedatives clients with the primary exact drug unknown. Of which 3 and 1 were new clients for respectively Opiates and Cocaine.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data

(3) Data are from 1st of April 2009 to 31st March 2010.

See also 'tdi-10-p12345678-07-Age distribution summary.xls' 'partvii',' partviii' and 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2011 REITOX National Reports - Table TDI Inpatient Treatment Centres

Page last updated: Monday, 09 July 2012